Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 70 clinical trials
Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia

Vitamin C is significant to human body and plays a role in reducing inflammatory response and preventing common cold. In addtion, a few studies have shown that vitamin C deficiency is related to the increased risk and severity of influenza infections.

respiratory tract infection
respiratory infection
coronavirus infection
antiviral drugs
pneumonia
  • 0 views
  • 16 Feb, 2024
  • 1 location
Selfcare MAnagement InteRvenTion in COPD (SMART COPD)

To evaluate whether a digital support and communication platform for COPD patients after 6 months provides: Decreased breathlessness on the basis of modified medical research council dyspnea scale [mMRC] Improved health status and symptom relief based on COPD assessment scale [CAT] Improved quality of life based on EQ-5D Reduction in …

dyspnea
  • 0 views
  • 05 Aug, 2020
A Study to Evaluate Efficacy and Safety of PTC299 in Hospitalized Participants With Coronavirus (COVID-19)

This is a randomized, double-blind, placebo-controlled, multicenter, 28-day study of adult participants hospitalized with COVID-19, with a safety follow-up telephone call at Day 60.

acute respiratory syndrome (sars)
fever
coronavirus infection
x-rays
chest x-ray
  • 0 views
  • 16 Feb, 2024
  • 5 locations
Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation

The purpose of this prospective, Phase 2, multicenter, blinded, randomized placebo controlled study is to demonstrate that early treatment with mavrilimumab prevents progression of respiratory failure in patients with severe COVID-19 pneumonia and clinical and biological features of hyper-inflammation.

acute respiratory syndrome (sars)
mavrilimumab
fever
acute respiratory failure
x-rays
  • 0 views
  • 01 Feb, 2023
  • 1 location
Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation

The purpose of this prospective, Phase 2, multicenter, blinded, randomized placebo controlled study is to demonstrate that early treatment with mavrilimumab prevents progression of respiratory failure in patients with severe COVID-19 pneumonia and clinical and biological features of hyper-inflammation.

acute respiratory syndrome (sars)
mavrilimumab
fever
acute respiratory failure
x-rays
  • 0 views
  • 01 Feb, 2023
  • 2 locations
Quality-of-Life Management for COPD Patients

The investigators aim to investigate the effects of a telemonitoring and chatbot-based application of "Living well with COPD" (CAir) on health-related quality-of-life in patients with COPD.

  • 0 views
  • 05 Aug, 2020
Multiomics After Cold Pressor Test of People Who Are Unable to Have Headache

The investigators will measure multiomic changes (transcriptomics and metabolomics) after pain induction by Cold Pressor Test. 3 blood samples, two for RNA and one for metabolites are taken 5 minutes before a Cold Pressor Test and again 1 hour after the Cold Pressor Test.

after pain
pressor
5 minutes
headache
cold
  • 0 views
  • 16 Feb, 2024
  • 1 location
Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19

This phase III trial compares low dose whole lung radiation therapy to best supportive care plus physicians choice in treating patients with COVID-19 infection. Low dose whole lung radiation therapy may work better than the current best supportive care and physician's choice in improving patients' clinical status, the radiographic appearance …

acute respiratory syndrome (sars)
fever
discomforts
pneumonia
chest imaging
  • 0 views
  • 16 Feb, 2024
  • 1 location
Manual Trial Test

Manual Trial overview.

  • 0 views
  • 19 Jul, 2023
  • 5 locations
Effect of Nutritional Supplementation and Pulmonary Rehabilitation on the Clinical Status of HF and COPD

50% of patients with COPD die of cardiovascular causes, and they are at higher risk of developing HF, hospital readmissions, and death. Subjects with HF and COPD concomitant have alterations such as; systemic inflammation, loss of muscle mass and strength of both skeletal and respiratory muscles, reduced tolerance to exercise, …

bronchodilator
post bronchodilator spirometry
pulmonary disease
spirometry
lung disorder
  • 0 views
  • 16 Feb, 2024
  • 1 location